<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180926041143N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-01-02</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>The effect of topically-applied combined herbal cream on Striae gravidarum in nulligravida women</public_title>
      <acronym></acronym>
      <scientific_title>The effect of topically-applied combined herbal cream on prevention of Striae gravidarum in nulligravida women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-10-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>140</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/34071</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Randomization description: Randomization will be based on simple randomization. The method used to randomize will be a random number table. To hide random assignments, numbered drug containers with random number sequences will be used, Blinding description: For the primary blindness of the study, since the possibility of sampling is different between the two groups, pregnant women have no knowledge of the contents of the cans in the other group. The second stage of blinding is that the researcher's assistance in the field of training and delivery of cans does not have the information on the type of the groups and the contents of the cans, and only records the cans in the sample form when the code is delivered. The next steps are to get the worm by the manufacturer to fit the group that belongs to him. The final stage of blindness is in relation to the individual who will analyze the results. She is also unaware of the groups and intervention. The research team leader will only decode the codes after analyzing the results.</study_design>
      <phase>3</phase>
      <hc_freetext>Steriae Gravidarum.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Herbal cream consisting of Calendula, Chamomile, Geranium, Cocoa and soybean seeds on pregnancy stretch from 14-16 weeks of gestation in primiparous women, twice daily by 0.3 grams or a half teaspoon in all four areas From the body, including 1. Separate the umbilicus to the symphysis pubis 2. Immediately above the umbilical in the transverse direction, 3. The right side in the longitudinal direction, 4. The left side, in the longitudinal direction, and massage gently, until the end of pregnancy. This herbal cream is made by Tus Amithis Ariaia company, under the supervision of the Center for the Growth of the Buali Institute in Mashhad. Intervention 2: Control group: Placebo cream consisting of Calendula, Chamomile, Geranium, Cocoa and soybean seeds on pregnancy stretch from 14-16 weeks of gestation in primiparous women, twice daily by 0.3 grams or a half teaspoon in all four areas From the body, including 1. Separate the umbilicus to the symphysis pubis 2. Immediately above the umbilical in the transverse direction, 3. The right side in the longitudinal direction, 4. The left side, in the longitudinal direction, and massage gently, until the end of pregnancy. This herbal cream is made by Tus Amithis Ariaia company, under the supervision of the Center for the Growth of the Buali Institute in Mashhad.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is So far, there is no definite program and protocol in Mashhad University of medical sciences.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Somayeh Alirezaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Midwifery, School of Nursing &amp; Midwifery, Mashhad University of Medical Sciences, Ebn Sine St, Daneshgah Ave, Mashhad Town</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>38528512</zip>
        <telephone>+98 51 3852 8512</telephone>
        <email>Alirezaeis961@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Somayeh Alirezaei</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ebn Sina St, Daneshgah Ave</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>+98 51338591511</telephone>
        <email>Alirezaeis961@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Pregnant nullipara women                                                Gestational Age range 14-16 week                                                Age range 20-35 year                                                                     BMI range 18.5-25 Kg/m2                                                                No smoking                                                                                      Not having any chronic diseases (Cardiovascular, Hypertension, diabetes, ...)</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>35 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>ster</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Herbal cream consisting of Calendula, Chamomile, Geranium, Cocoa and soybean seeds on pregnancy stretch from 14-16 weeks of gestation in primiparous women, twice daily by 0.3 grams or a half teaspoon in all four areas From the body, including 1. Separate the umbilicus to the symphysis pubis 2. Immediately above the umbilical in the transverse direction, 3. The right side in the longitudinal direction, 4. The left side, in the longitudinal direction, and massage gently, until the end of pregnancy. This herbal cream is made by Tus Amithis Ariaia company, under the supervision of the Center for the Growth of the Buali Institute in Mashhad.</i_keyword>
      <i_keyword>Control group: Placebo cream consisting of Calendula, Chamomile, Geranium, Cocoa and soybean seeds on pregnancy stretch from 14-16 weeks of gestation in primiparous women, twice daily by 0.3 grams or a half teaspoon in all four areas From the body, including 1. Separate the umbilicus to the symphysis pubis 2. Immediately above the umbilical in the transverse direction, 3. The right side in the longitudinal direction, 4. The left side, in the longitudinal direction, and massage gently, until the end of pregnancy. This herbal cream is made by Tus Amithis Ariaia company, under the supervision of the Center for the Growth of the Buali Institute in Mashhad.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The number, Severity and Size of Steriae Geravidarum based on Atwal  Scoring. Timepoint: Evaluation of Steriae Gravidarum at 27-30 and 38-40 of Gestational Age. Method of measurement: The numerical scoring system of Atwal.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-10-03</approval_date>
        <contact_name>Ethic committe of Mashhad University of Medical Sciences</contact_name>
        <contact_address>Mashhad University of Medical Sciences, Num 18, Daneshgah Ave, Mashhad Town Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
